Fate Therapeutics (FATE) PT Raised to $33 at Wedbush
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.43 +1.67%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Fate Therapeutics (NASDAQ: FATE) to $33.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Science Applications (SAIC) PT Raised to $140 at Jefferies
- Kazia Therapeutics (KZIA) PT Raised to $40 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
